NEWT vs TCPC

NewtekOne presents a classic 'value trap' profile, characterized by a very weak Piotroski F-Score of 2/9 indicating deteriorating fundamental health. While the stock is significantly undervalued relative to its Graham Number ($24.45) and Intrinsic Value ($15.26), this is offset by negative earnings growth (-6.00% YoY) and a high Debt/Equity ratio of 2.07. The strong dividend yield of 6.05% provides a floor, but the lack of growth and poor health metrics prevent a bullish rating. The discrepancy between the deep value metrics and the bearish technical trend suggests the market is pricing in fundamental risks.

TCPC exhibits severe financial deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a bearish technical trend of 0/100. While the stock trades at a significant discount to book value (P/B 0.61), this appears to be a value trap given the collapsing revenue (-28.30%) and EPS (-30.0%). Most critically, the 21.20% dividend yield is unsustainable, evidenced by a payout ratio of 377.78%, indicating the company is returning capital it is not earning. The combination of negative ROE and declining growth suggests a fundamental breakdown in the business model.